Literature DB >> 33206975

Digital Coaching Strategies to Facilitate Behavioral Change in Type 2 Diabetes: A Systematic Review.

Bradley D Gershkowitz1, Conor J Hillert1, Bradley H Crotty1.   

Abstract

CONTEXT: In this systematic review, we focus on the clinical impact of digital tools for providing health coaching, education, and facilitating behavior in patients with prediabetes or type 2 diabetes. Our approach was designed to provide insights for clinicians and health care systems that are considering adopting such digital tools. EVIDENCE ACQUISITION: We searched the CINAHL, Scopus, and Ovid/MEDLINE databases using PRISMA guidelines for studies that reported digital coaching strategies for management and prevention of type 2 diabetes published from January 2014 to June 2019. Articles were reviewed by 2 independent blinded reviewers. Twenty-one articles met inclusion criteria. EVIDENCE SYNTHESIS: We found that 20 of 21 studies in our analysis showed statistically significant improvements in at least one measure of diabetes control including HbA1c, weight loss, fasting blood glucose, and BMI. Studies that reported weight loss percentage from baseline at 1 year reported values ranging from -3.04% to -8.98%, similar to outcomes with traditional coaching in the Diabetes Prevention Program (N = 4). Additionally, all studies that included a comparison group of in-person or telephone-based coaching showed statistically better or similar outcomes in the digital coaching group (N = 5).
CONCLUSIONS: The evidence reported in this systematic review suggests that digital health coaching offers a promising strategy for long-term management and prevention of type 2 diabetes in diverse populations with similar benefits to in-person or telephone-based health coaching. We argue that, with the potential to treat large numbers of individuals in diverse geographic locations, digital coaching offers a promising solution to the rapid increase in diabetes prevalence.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Type 2 diabetes mellitus; behavior change; digital medicine; health coaching; mHealth; telemedicine

Year:  2021        PMID: 33206975     DOI: 10.1210/clinem/dgaa850

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

2.  Digital Health Coaching for Type 2 Diabetes: Randomized Controlled Trial of Healthy at Home.

Authors:  Kimberly R Azelton; Aidan P Crowley; Nicholas Vence; Karin Underwood; Gerald Morris; John Kelly; Matthew J Landry
Journal:  Front Digit Health       Date:  2021-11-25

3.  Improving Outcomes Through Personalized Recommendations in a Remote Diabetes Monitoring Program: Observational Study.

Authors:  Sowmya Kamath; Karthik Kappaganthu; Stefanie Painter; Anmol Madan
Journal:  JMIR Form Res       Date:  2022-03-21

4.  Patient engagement strategies for adults with chronic conditions: an evidence map.

Authors:  Hanan Aboumatar; Samantha Pitts; Ritu Sharma; Asar Das; Brandon M Smith; Jeff Day; Katherine Holzhauer; Sejean Yang; Eric B Bass; Wendy L Bennett
Journal:  Syst Rev       Date:  2022-03-05

5.  Telemedicine implementation and use in community health centers during COVID-19: Clinic personnel and patient perspectives.

Authors:  Denise D Payán; Jennifer L Frehn; Lorena Garcia; Aaron A Tierney; Hector P Rodriguez
Journal:  SSM Qual Res Health       Date:  2022-02-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.